Retatrutide 20mg & Tirzepatide 40mg Research Stack – High-Purity GIP & GLP-1 Dual Agonist for Metabolic Modeling
£280.47
A potent synergistic combination of Retatrutide and Tirzepatide. This high-dose dual/triple agonist blend is designed for advanced multi-pathway weight research.
Description
What is Retatrutide 20mg + Tirzepatide 40mg (CAS 2381089-83-2 & 2023788-19-2)?
The Retatrutide 20mg + Tirzepatide 40mg combination is an elite-tier research blend featuring two of the most potent incretin mimetics in modern biotechnology. Retatrutide (CAS 2381089-83-2) is a GIP/GLP-1/GCGR triple agonist, while Tirzepatide (CAS 2023788-19-2) is a GIP/GLP-1 dual agonist. This specific high-dose ratio is engineered for complex laboratory studies investigating the synergistic effects of targeting three distinct metabolic receptors simultaneously.
At 99Purity-Peptide, we provide this synergistic blend as a vacuum-sealed, lyophilized powder. This formulation is optimized for advanced researchers exploring the limits of cellular energy expenditure, insulin sensitivity, and multi-receptor metabolic regulation.
Retatrutide + Tirzepatide Mechanism of Action and Research
The scientific significance of this blend lies in its Triple/Dual-Agonist Synergy. By combining these compounds, researchers can observe the activation of the Glucagon-like Peptide-1 (GLP-1), Glucose-dependent Insulinotropic Polypeptide (GIP), and Glucagon (GCG) receptors. While GLP-1 and GIP primarily manage satiety and glucose-dependent insulin secretion, the Glucagon receptor activation from the Retatrutide component is researched for its unique ability to increase basal metabolic rate and energy expenditure.
In comparative metabolic research, this 20mg/40mg blend is used to study the “saturation effect” of incretin receptors. Research models utilize this high-dose combination to investigate the reversal of severe metabolic syndrome markers and the optimization of lipid mobilization through simultaneous multi-pathway signaling.
Trending Research Topics & High-Authority Insights:
Triple-Agonist Energy Expenditure: Investigating the added benefit of Glucagon receptor activation in weight studies.
Incretin Receptor Saturation: Studying the physiological limits of GIP and GLP-1 pathway stimulation.
Retatrutide 20mg + Tirzepatide 40mg Specifications
| Feature | Specification |
| Product Name | Retatrutide 20mg + Tirzepatide 40mg Blend |
| Available Strengths | Retatrutide 20mg + Tirzepatide 40mg |
| Physical Appearance | White Lyophilized Powder |
| Purity | ≥ 99% (HPLC/MS Verified) |
| Molecular Formula | $C_{221}H_{342}N_{46}O_{68}$ (Reta) / $C_{225}H_{348}N_{48}O_{68}$ (Tirz) |
| CAS Number | 2381089-83-2 & 2023788-19-2 |
| Verification | 3rd-Party Lab Tested with COA |
| Storage Instructions | Store at -20°C (Long-term); 2-8°C after reconstitution |
Retatrutide 20mg + Tirzepatide 40mg Key Features & Benefits
Pioneering Multi-Pathway Research: Simultaneously targets GIP, GLP-1, and GCGR receptors for maximum research depth.
High-Dose Synergistic Profile: Designed for advanced protocols requiring higher concentrations of metabolic agonists.
Ultra-High Purity Synthesis: Synthesized at 99%+ purity to ensure the integrity of complex multi-peptide research data.
Sterile Lyophilized Preparation: Vacuum-sealed to resist environmental degradation and ensure long-term stability.
Independently Verified Identity: Each vial is confirmed via HPLC and Mass Spectrometry to guarantee exact peptide ratios and purity levels.
Retatrutide 20mg + Tirzepatide 40mg FAQ
Why combine Retatrutide and Tirzepatide in a single research vial?
This blend allows researchers to study the combined impact of triple and dual agonists. It is used to investigate whether additional Glucagon receptor stimulation (from Retatrutide) provides superior metabolic optimization compared to standard GLP-1/GIP signaling.
What is the advantage of the 20mg/40mg high-dose specification?
The high-dose format is optimized for intensive research protocols or long-term studies, reducing the need for frequent vial changes and ensuring a consistent concentration across the study duration.
How should I reconstitute this dual-peptide blend?
The lyophilized powder is typically reconstituted with bacteriostatic water. Researchers should handle the vial with care, swirling gently to ensure both peptides dissolve completely without damaging the delicate molecular structures.
Is the purity of both peptides verified independently?
Yes. At 99Purity-Peptide, we verify both the Retatrutide and Tirzepatide components via HPLC and MS testing to ensure each vial meets our strict 99%+ purity guarantee.
Why Buy Retatrutide 20mg + Tirzepatide 40mg online from 99Purity-Peptide?
Scientific Precision in Blending: We specialize in high-concentration peptide ratios, ensuring that every vial provides the exact 20mg/40mg balance required for accurate experimental results.
Discreet Global Logistics: We understand the necessity of research privacy. All orders are dispatched in unbranded, secure packaging with tracked, expedited shipping to the USA, UK, and Europe.
Entrepreneurial Excellence: As a boutique biotech supplier, we offer 1-2 business day dispatch and maintain rigorous quality standards for high-demand metabolic research compounds.
Total Research Transparency: From detailed COAs to professional technical support, we provide the service and quality that professional metabolic researchers demand.
Payment Support & Logistics
Secure Payment Options: We support multiple secure gateways, including Credit Cards, Cryptocurrency (USDT, USDC), PayPal, and Bank Transfers.
Global Shipping: Fast, tracked delivery available to the United States, United Kingdom, and Europe.
Processing Time: All orders are professionally handled and dispatched within 1-2 business days after payment confirmation.
Regulatory Disclaimer
99Purity-Peptide is a chemical supplier. We are not a compounding pharmacy or an outsourcing facility as defined under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act). All products are strictly for research, laboratory, or analytical use only and are NOT for human consumption.
References & Academic Links
Jastreboff, A. M., et al. (2023). “Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial.” The New England Journal of Medicine.
Frias, J. P., et al. (2021). “Tirzepatide versus Semaglutide Once Weekly.” The New England Journal of Medicine.
Additional information
| Weight | 0.5 kg |
|---|---|
| Dimensions | 25 × 20 × 20 cm |
| Strength | (20mg+40mg)*10Vials |
1 review for Retatrutide 20mg & Tirzepatide 40mg Research Stack – High-Purity GIP & GLP-1 Dual Agonist for Metabolic Modeling
Related products
-

5-AMINO-1MQ 50mg – NNMT Inhibition Research
Rated 5.00 out of 5£17.88 – £67.57Price range: £17.88 through £67.57 Select options This product has multiple variants. The options may be chosen on the product page -

MOTS-c (Mitochondrial-Derived Peptide) 40mg – Mitochondrial Research Peptide
Rated 5.00 out of 5£70.43 – £291.79Price range: £70.43 through £291.79 Select options This product has multiple variants. The options may be chosen on the product page -

Cagrilintide 10mg – Specialized Analytical Standard for Incretin Research
Rated 5.00 out of 5£89.49 – £288.11Price range: £89.49 through £288.11 Select options This product has multiple variants. The options may be chosen on the product page -

Cagrilintide & Semaglutide Stack (1:1 Ratio)10mg+10mg – Comparative Study on Energy Homeostasis
Rated 5.00 out of 5£77.99 – £291.79Price range: £77.99 through £291.79 Select options This product has multiple variants. The options may be chosen on the product page








Poblen –
Reliable retailers provide a great shopping experience!